1-methyl-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one | 283172-75-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 1-methyl-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one
• 英文别名: 1-N-Methyl-3,4,5,6-tetrahydro-1H-azepino [5,4,3-cd]indol-6-one；3-Methyl-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
• CAS: 283172-75-8
• 化学式: C₁₂H₁₂N₂O
• 分子量: 200.24
• InChiKey: JBIJEHLYXDQFGI-UHFFFAOYSA-N

物化性质

• 熔点：
  179-180 °C
• 沸点：
  494.3±24.0 °C(Predicted)
• 密度：
  1.31±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  34
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-methyl-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one 在 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 6.08h， 生成 10-[(2,2-dimethyl-4H-1,3-benzodioxin-4-yl)methyl]-3-methyl-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraene
  参考文献：
  名称：

  A Synthetic Approach to Nomofungin/Communesin B

  摘要：

  [GRAPHICS]A highly stereoselective intramolecular cycloaddition of an indole tethered to an aza-ortho-xylylene intermediate effects the rapid construction of a substantial portion of the ring system of the cytotoxic natural product communesin B. An analogous cycloaddition involving an orthoquinone methide intermediate provides an adduct that clearly revealed that the structural assignment for nomofungin was in error.

  DOI：

  10.1021/ol034407v
• 作为产物：
  描述：

  1-甲基-1H-吲哚-4-羧酸甲酯 在 platinum(IV) oxide 对叔丁基邻苯二酚 、 氢气 作用下， 以 乙醇 、 xylene 为溶剂， 反应 99.0h， 生成 1-methyl-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one
  参考文献：
  名称：

  A Synthetic Approach to Nomofungin/Communesin B

  摘要：

  [GRAPHICS]A highly stereoselective intramolecular cycloaddition of an indole tethered to an aza-ortho-xylylene intermediate effects the rapid construction of a substantial portion of the ring system of the cytotoxic natural product communesin B. An analogous cycloaddition involving an orthoquinone methide intermediate provides an adduct that clearly revealed that the structural assignment for nomofungin was in error.

  DOI：

  10.1021/ol034407v

文献信息

• Tricyclic inhibitors of poly(ADP-ribose) polymerases
  申请人：Agouron Pharmaceuticals, Inc.

  公开号：US06495541B1

  公开（公告）日：2002-12-17

  Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapuetics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and nuerodegenerative disease. As cancer therapuetics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.

  以下公式化合物是聚(ADP核糖基)转移酶（PARP）抑制剂，可用于治疗癌症并改善中风、头部创伤和神经退行性疾病的影响。作为癌症治疗药物，本发明的化合物可与细胞毒性药物和/或放射线结合使用。
• TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES
  申请人：AGOURON PHARMACEUTICALS, INC.

  公开号：EP1140936B1

  公开（公告）日：2004-03-17
• Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye
  申请人：Zhang Jinzhong

  公开号：US20080305994A1

  公开（公告）日：2008-12-11

  A composition for treating, reducing, ameliorating, alleviating, or preventing a dry eye condition or an opthalmologic disorder that has an etiology in inflammation comprises an inhibitor of activity of poly(ADP-ribose) polymerase (“PARP”). The composition can also include a modulator of pro-inflammatory gene expression.
• US6495541B1
  申请人：——

  公开号：US6495541B1

  公开（公告）日：2002-12-17
• US6977298B2
  申请人：——

  公开号：US6977298B2

  公开（公告）日：2005-12-20